Corporate Earnings Drive Market Focus Amid Economic Data Releases

By / / Breaking News

  • Abbott Laboratories (ABT) reported Q2 2025 adjusted EPS of $1.26 on net sales of $11.14 billion, both slightly surpassing analyst expectations of $1.25 and $11.06 billion, respectively. Organic sales growth, however, came in slightly below estimates at +6.9% versus an estimated +7.03%. The company projects Q3 adjusted EPS between $1.28 and $1.32 and revised its full-year adjusted EPS outlook to $5.10 to $5.20, narrowing the previous range of $5.05 to $5.25.

  • Travelers Companies (TRV) delivered a robust second quarter 2025 performance, with core EPS of $6.51, significantly exceeding the estimated $3.60. The insurer's revenue surged 7.4% year-over-year to $12.12 billion, beating the consensus of $11.0 billion. This strong showing was bolstered by an excellent underlying combined ratio of 84.7% and a total combined ratio of 90.3%.

  • Pre-market trading saw significant movement following various earnings reports. Taiwan Semiconductor Manufacturing Company (TSM) climbed 4% as its net profit beat expectations and reached a record high, driven by strong demand for AI chips and a robust next-quarter revenue outlook. Conversely, Elevance Health (ELV) shares dropped 3% after the company missed profit estimates, issued a weak full-year outlook, and warned on rising costs. Meanwhile, General Electric (GE) saw its shares rise 2.5% after reporting top and bottom-line beats and raising its guidance.

  • Bristol-Myers Squibb (BMY) and Pfizer (PFE) announced a new direct-to-patient purchasing option for their anticoagulant medication, Eliquis (ELIQUIS). Starting September 8, eligible U.S. patients will be able to buy Eliquis directly at over a 40% discount to the current list price through the expanded ELIQUIS 360 support program.

  • Expectations for June U.S. retail sales are varied, with Bank of America (BAC) anticipating a 0.9% rise in the control group, while Goldman Sachs (GS) projects a 0.4% increase in core control retail sales. These figures are closely watched as consumer spending remains a key driver of economic activity.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top